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Abstract 
Background: Severe metabolic acidosis and acute kidney injury are major causes of mortality in children with severe 
malaria but are often underdiagnosed in low resource settings.
Methods: A retrospective analysis of the ‘Artesunate versus quinine in the treatment of severe falciparum malaria in 
African children’ (AQUAMAT) trial was conducted to identify clinical features of severe metabolic acidosis and uraemia 
in 5425 children from nine African countries. Separate models were fitted for uraemia and severe metabolic acidosis. 
Separate univariable and multivariable logistic regression were performed to identify prognostic factors for severe 
metabolic acidosis and uraemia. Both analyses adjusted for the trial arm. A forward selection approach was used for 
model building of the logistic models and a threshold of 5% statistical significance was used for inclusion of variables 
into the final logistic model. Model performance was assessed through calibration, discrimination, and internal valida-
tion with bootstrapping.
Results: There were 2296 children identified with severe metabolic acidosis and 1110 with uraemia. Prognostic 
features of severe metabolic acidosis among them were deep breathing (OR: 3.94, CI 2.51–6.2), hypoglycaemia (OR: 
5.16, CI 2.74–9.75), coma (OR: 1.72 CI 1.17–2.51), respiratory distress (OR: 1.46, CI 1.02–2.1) and prostration (OR: 1.88 
CI 1.35–2.59). Features associated with uraemia were coma (3.18, CI 2.36–4.27), Prostration (OR: 1.78 CI 1.37–2.30), 
decompensated shock (OR: 1.89, CI 1.31–2.74), black water fever (CI 1.58. CI 1.09–2.27), jaundice (OR: 3.46 CI 2.21–5.43), 
severe anaemia (OR: 1.77, CI 1.36–2.29) and hypoglycaemia (OR: 2.77, CI 2.22–3.46)
Conclusion: Clinical and laboratory parameters representing contributors and consequences of severe metabolic 
acidosis and uraemia were independently associated with these outcomes. The model can be useful for identifying 
patients at high risk of these complications where laboratory assessments are not routinely available.
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Background
A major challenge to preventing mortality from malaria 
is early identification and mitigation of clinical states pre-
dictive of death from malaria. The World Health Organi-
zation (WHO) Africa region bears the brunt as malaria 
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80% of all malaria related deaths [1]. Despite prompt 
administration of anti-malarials, 5.8%–24% of child-
hood deaths from severe  malaria occur on the first day 
of admission [2, 3]. Metabolic acidosis and acute kidney 
injury are two of three (in addition to coma) complica-
tions of malaria most predictive for a fatal outcome of 
severe malaria [2, 4–10]. However, diagnosis of meta-
bolic acidosis or acute kidney injury requires laboratory 
facilities beyond the basic test facilities often available. 
Assessing the base excess to quantify metabolic acidosis, 
requires a blood gas machine, and assessing plasma lac-
tate, which can be a surrogate maker for acidosis, is often 
not routinely available. Acute kidney injury can be iden-
tified rapidly if the patient with severe malaria is anuric. 
However, up to 80% of severe malaria patients with acute 
kidney injury (AKI) are non-oliguric [11–13]. Identify-
ing these children with a high risk of having AKI could be 
beneficial in resource-poor settings.
In children with severe malaria, metabolic acidosis 
is present in up to 50% of cases, and is strongly associ-
ated with a fatal outcome [10, 14, 15]. Metabolic acido-
sis in malaria is mainly a result of increased lactate (LA) 
production from anaerobic glycolysis and to a smaller 
extent from Plasmodium falciparum parasites [5, 8]. 
The plasma and urinary acids α-hydroxybutyric acid 
(αHBA), β-hydroxybutyric acid (βHBA), and p-hydroxy-
phenyllactic acid (HPLA), also contribute to metabolic 
acidosis [5–7, 16]. Failure of hepatic gluconeogenesis 
and lack of kidney clearance due to acute kidney injury 
commonly compound this problem [8, 16]. These bio-
chemical changes cause physiologic responses and clini-
cal signs that can be used to identify metabolic acidosis 
in patients.
The clinical signs associated with metabolic acidosis are 
varied and there is need for reliable criteria to make this 
diagnosis clinically. Although deep breathing is a sign of 
respiratory distress most commonly described in relation 
to metabolic acidosis, its association has been contested 
in several studies [2, 14, 17, 18]. Similarly, there is varied 
significance in the association of metabolic acidosis and 
the presence of coma or convulsions [17, 19]. Due to the 
overlapping nature of these and other clinical signs, it is 
challenging to identify metabolic acidosis clinically [20].
In children, acute kidney injury is underdiagnosed 
and presents a growing concern for kidney disease 
as a global health problem in Africa [21]. In Nigeria, 
malaria was the third commonest cause of AKI among 
children admitted to a nephrology unit [13]. Among 
Congolese children in intensive care, black water fever 
from malaria was the predominant cause of AKI [12]. 
In Uganda, nearly half (45.5%) of children with severe 
malaria had kidney disease improving global outcomes 
defined AKI [21]. Challenges in diagnosing AKI in 
resource limited settings mean that it is underdiag-
nosed consequently undertreated, leading to increasing 
mortality and an increased risk of chronic kidney injury 
and neurocognitive disorders [4, 10, 21–23].
Having reliable surrogate markers that identify meta-
bolic acidosis and kidney injury could improve their 
diagnosis. However, studies on clinical signs of severe 
metabolic acidosis and AKI in malaria often have low 
sensitivity and high inter-observer variability [18, 20, 
24]. Reliably identifying these complications of malaria 
would improve the efficiency of therapeutic approaches 
within the first 24 h of admission.
The aim of this study was to develop prognostic mod-
els for identifying factors related to severe metabolic 
acidosis and kidney injury using clinical signs among 
children admitted with severe malaria.
Methods
Study design, study population and sampling
This is a secondary analysis of the open label ’Artesu-
nate versus quinine in the treatment of severe falcipa-
rum malaria in African children’ randomized controlled 
trial (AQUAMAT) in eleven centres of nine African 
countries [25]. The main aim of the study was to com-
pare mortality outcomes in the quinine and artesu-
nate arms of the trial. Selected patients had a positive 
blood antigen dipstick test for Plasmodium falciparum 
histidine rich protein2, and a physician’s clinical diag-
nosis of severe malaria. Severe malaria was defined as 
patients with a positive malaria test and at least one of 
the WHO symptoms [25]. Patients with previous treat-
ment of quinine (40  mg/kg on first day and 30  mg/kg 
on any subsequent day) or artesunate derivatives within 
24  h preceding admission to the study were excluded 
[25].
The AQUAMAT randomized trial enrolled 5425 chil-
dren from 11 centres in nine African countries between 
October 2005 and July 2010. The participating coun-
tries and their number of participants are: The Gambia 
(502, 9.3%), Ghana (436, 8%), Kenya (442, 8.3%), Tan-
zania (1461, 26.9%), Nigeria (450, 8.3%), Uganda (663, 
12.2%), Mozambique (664, 12.2%), Rwanda (386, 7.1%), 
and Democratic Republic of the Congo (422, 7.8%) [25]. 
There were 2713 patients in the artesunate arm and 2713 
patients in the quinine arm analysed by intention to treat 
[25]. Overall mortality was 9.7% (527), with 230 (8.5%) 
deaths in the artesunate group and 297 (10.9%) deaths 
in the quinine group [25]. The study supported adopting 
artesunate as the first-line of treatment for P. falciparum 
malaria in children. Other analyses of mortality findings 
have been discussed in secondary analyses of the AQUA-
MAT study [4, 25].
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Definitions of model outcomes and candidate predictors
Literature on severe metabolic acidosis and AKI in 
children with severe malaria were searched to identify 
features associated with these complications that were 
studied or previously described (Fig. 1). Candidate pre-
dictors that were complications of malaria and those 
that either caused or resulted from severe metabolic 
acidosis or AKI were included. For severe metabolic 
acidosis, this includes contributing factors like anae-
mia and consequences of metabolic acidosis, like deep 
breathing [17, 26]. Similarly, for AKI candidate predic-
tors include causative features like black water fever 
and hypovolaemia [27, 28].
The outcome and candidate predictor cut-off points 
were selected according to WHO classifications for 
severe metabolic acidosis and kidney injury in chil-
dren with severe malaria [29]. Accordingly, severe 
metabolic acidosis was defined as a base excess of less 
than 8 mmol/l [29]. This cut-off for base excess has also 
been used in studies in similar settings [14, 20]. Kid-
ney injury was assessed using uraemia, defined as a 
blood urea nitrogen (BUN) of more than 20 mg/dl [29]. 
Candidate predictors for each outcome were selected 
based on WHO signs of severe malaria and variables 
described in literature to be associated with each out-
come. Ideally, AKI should have been assessed and 
staged by kidney disease: improving global outcomes 
(KDIGO) criteria, using serum creatinine and urine 
output [30]. Only blood urea nitrogen was collected in 
this study, thus limiting the assessment to uraemia.
Definitions of parameters
Severe metabolic acidosis: Base Excess <  − 8  mmol/l.
Uraemia: Blood Urea Nitrogen > 20 mg/dl.
Severe anaemia: Hb < 5 g/dl.
Mild anaemia: Hb > 5, < 10 g/dl.
Statistical analysis
The forward selection method was used for inclusion of 
predictors for the diagnosis of severe metabolic acidosis 
and uraemia. To select candidate predictors for each out-
come, a univariable logistic regression was used and a 5% 
significance level threshold for inclusion of variables into 
the model using forward selection approach.
Key predictors and some selected patient demograph-
ics were included in the multivariable logistic regression 
analysis irrespective of statistical significance. The mul-
tivariable model was adjusted for trial arm (quinine and 
artesunate), patient demographics (including country of 
origin) and, included only clinical variables that were sta-
tistically significant.
The performance of the predictive models was assessed 
through calibration and discrimination. A calibration 
plot of predicted observed against predicted events was 
plotted for 10 equal groups to measure the agreement 
in probabilities of developing the outcomes. Model dis-
crimination was assessed by area under the curve (AUC) 
of a receiver operating characteristic (ROC). Using the 
sampling with replacement method, 5000 simulations of 
the model were computed to assess the generalizability of 
Fig. 1 Conceptual framework of features associated with severe metabolic acidosis and acute kidney injury in children with severe falciparum 
malaria [31]
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the models by comparing the bootstrapped c-index and 
confidence interval to the AUC obtained from the logistic 
model.
This data was analysed using Stata software package 
version 14.2, StataCorp, College Station, TX: StataCorp 
LP.
Ethical considerations
Ethical approval for the AQUAMAT study, registered 
under ISRCTN50258054, was obtained from each par-
ticipating institutional or national ethics committee in 
addition to the Oxford Tropical Research Ethics com-
mittee [25]. The use of data for this secondary analysis 
was approved by the Oxford-Mahidol research Unit Data 
Access Committee through an application for ‘Data-
sets under the Custodianship of Mahidol Oxford Tropi-
cal Medicine Research Unit (MORU) Tropical Network’. 
The database used for this analysis was de-identified and 
anonymized.
Results
The baseline characteristics (Table  1) were collected 
at admission and there were no significant differences 
between the artesunate and quinine group.
Prognostic factors of metabolic acidosis
In this study, 50.1% (2,296) of children presented with 
severe metabolic acidosis [base excess less than 8 mmol/l] 
and there was no significant difference between males 
(48.9%) and females (51.3%). About a quarter, 24.1% 
had normal acid–base state and 25.8% had mild meta-
bolic acidosis (BE: more than 8  mmol/l and less than 
3 mmol/l). Among those who died, 82% (367), had severe 
metabolic acidosis. Survivors were 81% were less likely 
to have severe metabolic acidosis compared to those 
who died (OR = 0.19, 95% CI 0.15–0.24, p-value: < 0.001). 
Severe metabolic acidosis was present in 50.8% (1162) of 
patients in the artesunate arm and 49.5% (1134) of chil-
dren in the quinine arm.
Table 1 Baseline characteristics of patients admitted to the AQUAMAT trial
Variable N (%) Artesunate N (%) Quinine N (%)
Sample size: 5425
Patient demographics
 Congo 422 (7.8) 212 (50.2) 210 (49.8)
 Gambia 502 (9.3) 250 (49.8) 252 (50.2)
 Ghana 436 (8) 218 (50) 218 (50)
 Kenya 442 (8.3) 219 (49.6) 223 (50.5)
 Mozambique 664 (12.2) 332 (50) 332 (50)
 Nigeria 450 (8.3) 226 (50.2) 224 (49.8)
 Rwanda 386 (7.1) 194 (50.3) 192 (49.7)
 Tanzania 1461 (26.9) 729 (49.9) 732 (50.1)
 Uganda 663 (12.2) 333 (50.2) 330 (49.8)
Age (Median, IQR: 25–75) 2 (1- 4) 2 (1–4) 2 (1−4)
Females 2611 (48.1) 1298 (47.7) 1316 (48.5)
Male 2815 (51.9) 1418 (52.3) 1397 (51.5)
Clinical characteristics
 Coma at admission (BCS <  = 2) 1823 (33.6) 881 (48.3) 942 (51.7)
 Severe prostration (Not able to breast feed < 6 m or able to sit > 6 m) 2974 (54.8) 1505 (50.6) 1469 (49.3)
 Convulsions (> 30 min) 1355 (31.2) 637 (47) 718 (52.9)
 Decompensated shock (BP < 70mmhg) 178 (3.3) 88 (49.4) 90 (50.6)
 Deep breathing 938 (17.3) 495 (52.8) 443(47.2)
 Respiratory distress (costal in drawing/ recession / respiratory insufficiency 867 (15.9) 439 (50.6) 428 (49.4)
 Symptomatic severe anaemia (severe pallor combined with respiratory distress) 2213 (40.8) 1131 (51.1) 1082 (48.9)
 Black water fever (haemoglobinuria) 237 (4.4) 121 (51.1) 116 (48.9)
 Severe jaundice 114 (2.1) 55 (48.3) 59 (51.8)
 Anuria / Oliguria (in adults and children—History) 7 (0.1) 6 (85.7) 1 (14.3)
 Hypoglycaemia (MB-Stix < 3 mmol/L or clinical improvement after iv glucose) 557 (10.3) 278 (49.9) 279 (50.1)
 Hb g/dl: Mean: 6.5, IQR (4.8–8.8) 6.5 (4.6–8.8) 6.8 (4.6–8.8)
 BUN mg/dl: Mean 13, IQR: 9–20) 13 ( 9−21) 13 (9 –20)
 Base excess: Mean − 8.78, IQR:—13 to − 4) – 7 (−13 to − 4) – 8 (−8 to − 4)
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For the multivariable analysis (Table  2), every year 
increase in age was associated with a 21% decrease in 
likelihood of presenting with severe metabolic acidosis 
(OR: 0.79, CI 0.76–0.83).
The clinical features with the strongest association to 
severe metabolic acidosis were deep breathing (OR: 3.94, 
CI 2.51–6.2) and hypoglycaemia (OR: 5.16, CI 2.74–9.75).
In the multivariable analysis, children presenting with 
a coma were 1.72 times more likely to have severe meta-
bolic acidosis when compared to those without coma 
(CI 1.17–2.51). Conversely, children who presented with 
convulsions were 30% less likely to have severe metabolic 
acidosis compared to those without convulsions (OR: 0.7, 
CI 0.53–0.93).
Children with respiratory distress (OR: 1.46, CI 1.02–
2.1) and prostration (OR: 1.88 CI 1.35–2.59) more likely 
to have metabolic acidosis compared to those who did 
not have these signs.
Model performance is shown using a calibration plot in 
Fig. 2 of observed against predicted events plotted for 10 
risk groups (c-index = 0.76, slope = 0.9). The Area Under 
the Curve (AUC) (Fig.  2) based on the final model was 
0.77. The model has a positive predictive value (PPV) of 
88.7% and a Negative Predictive value (NPV) of 43.1%. 
The sensitivity was 67.3% and the specificity was 74.2%. 
The model had internal validation performed using 
bootstrapping with 5000 simulations resulting in AUC of 
0.78 (95% CI 0.76–0.79).
Prognostic factors of uraemia
Among children admitted with severe malaria in this 
study, 24.3% (1110) had uraemia. Uraemia was present 
among 217 participants (49.2%) out of 441 who died 
(missing data on BUN for 86 results) and of the 4120 
participants who survived, 21.7% (893) had Uraemia. 
Table 2 Univariable and multivariable analysis of admission features and their association with severe metabolic acidosis
Respiratory distress = costal in drawing/ recession / respiratory insufficiency; Hyperparasitaemia =  > 500 Parasites per high power field
Variable Sample size: 5425 Univariable analysis Multivariable analysis
N (%) Severe 
Metabolic 
Acidosis N (%)
Odds ratio 95% CI P-Value Odds ratio 95% CI P Value
Gender: female (reference) and male 2611 (48.1) 1143 (51.3)
2815 (51.9) 1153 (48.9) 0.91 0.81–1.02 0.11 0.92 0.19–4.55 0.92
Age 5426 0.78 0.76–0.81  < 0.001 0.79 0.76–0.83  < 0.001
Coma (BCS <  = 2) 1823 (33.6) 776 (50.6) 1.03 0.91–1.16 0.646 1.72 1.17–2.51 0.005
Prostration 2974 (54.8) 1299 (52.3) 1.21 1.07–1.36 0.002 1.88 1.35–2.59  < 0.001
Convulsions (> 30 min) 169 2(31.2) 623 (43.4) 0.68 0.60–0.77  < 0.001 0.7 0.53–0.93 0.012
Decompensated shock: systolic BP < 70mhg 178 (3.3) 110 (71.9) 2.62 1.84–3.75  < 0.001 1.46 0.66–3.32 0.352
Respiratory distress 867 (15.9) 498 (67.8) 2.39 2.03–2.83  < 0.001 1.46 1.02–2.1 0.039
Deep breathing 938 (17.3) 731 (86.3) 8.74 7.11 –10.74  < 0.001 3.94 2.51–6.2  < 0.001
Black water fever (haemoglobinuria) 237 (4.4) 73 (40.6) 0.67 0.49–0.91 0.009 1.28 0.78–2.11 0.34
Symptomatic anaemia 114 (2.1) 55 (56.12) 1.28 0.86–1.92 0.23
Anuria / Oliguria 7 (0.1) 7 (100) 1 * *
Hyperparasitaemia 100 (1.8) 40 (42.6) 0.73 0.48–1.11 0.14
Mild anaemia (< 10—5) 2705 (55.0) 1139 (45.3) 1.21 1.02–1.43 0.027 0.73 0.54–0.98 0.04
Severe anaemia (< 5) 1431 (29.1) 841 (64.2) 2.6 2.16–3.13  < 0.001 0.79 0.55–1.12 0.19
Uraemia (BUN > 20) 1110 (24.3) 800 (73.4) 3.55 3.05-–4.13  < 0.001
Hypoglycaemia 557 (10.3) 434 (88.4) 9.11 6.87–12.09  < 0.001 5.16 2.74–9.75  < 0.001
Fig. 2 Calibration plot of severe metabolic acidosis model
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Those who survived were 71% less likely to have 
uraemia compared to those who died (OR: 0.29, CI 
0.23–0.35, p-value: < 0.001). The univariable analysis 
for factors associated with uraemia are shown in the 
Table 3.
After multivariable analysis (Table  3) and forward 
selection of predictors, factors associated with urae-
mia upon admission were; increasing age (OR: 1.08, 
CI 1.05–1.13), coma (OR: 3.18, CI 2.36–4.27), prostra-
tion (OR: 1.78 CI 1.37–2.30), decompensated shock 
(OR: 1.89, CI 1.31–2.74), black water fever (OR: 1.58, 
CI 1.09–2.27), jaundice (OR: 3.46 CI 2.21–5.43), mild 
anaemia (OR: 1.28, CI 1.01–1.62), severe anaemia (OR: 
1.77, CI 1.36–2.29) and hypoglycaemia (OR: 2.77, CI 
2.22–3.46).
The model performance was assessed using a cali-
bration plot (Fig.  3) of observed against predicted 
events for 10 groups and produced a c-index = 0.75, 
slope = 1.1). The AUC ROC for the final model was 
0.74. The sensitivity was 67.4% and the specificity was 
67.4%. The final model had a PPV of 39.9%, an NPV of 
86.5% and correctly classified 67.4% of the values.
The model had an internal validation performance 
of AUC = 0.74 (95% CI 0.72–0.76) using bootstrapping 
with 5000 simulations.
Discussion
Although severe metabolic acidosis and acute kidney 
injury are major causes of death from severe malaria, 
diagnosing them is challenging in low resource settings. 
This study identified clinical features of severe metabolic 
acidosis and uraemia in children with severe malaria at 
admission. The models described can be used to predict 
a group of children with a high chance of having severe 
Table 3 Univariable and multivariable analysis of clinical features associated with uraemia at admission
Severe Prostration: Not Able to breast feed < 6 m or able to sit > 6 m, Decompensated Shock: Children Systolic BP < 70mhg, Respiratory distress: costal in drawing/ 
recession / respiratory insufficiency, Hyperparasitaemia: > 500 parasites per high powered field
Variable Sample size: 5425 Univariable analysis Multivariable analysis
N (%) Acute 
kidney 
injury N(%)
Odds Ratio CI 95% P-value Odds Ratio CI 95% P-value
Age (Mean: 2 years IQR:25th -75th: 1–4) 1.04 1.01–1.07 0.003 1.08 1.05—1.13  < 0.001
Gender: female (reference), male 2611 (48.1) 533 (24.1) 1.03 0.89—1.18 0.688 1 0.86—1.16 0.97
Coma (BCS <  = 2) 1823 (33.6) 436 (28.8) 1.42 1.23–1.63  < 0.001 3.18 2.36—4.27  < 0.001
Severe prostration 2974 (54.8) 574 (23.1) 0.86 0.75–0.99 0.034 1.78 1.37—2.30  < 0.001
Convulsions (> 30 min) 1692 (31.2) 293 (20.6) 0.74 0.63–0.86  < 0.001 0.83 0.68—1.02 0.075
Decompensated shock 178 (3.3) 59 (39.3) 2.07 1.48–2.89  < 0.001 1.89 1.31—2.74 0.001
Respiratory distress 867 (15.9) 198 (27.1) 1.19 0.99–1.43 0.056 1.1 0.89—1.35 0.366
Deep breathing 938 (17.3) 255 (30.9) 1.5 1.27–1.78  < 0.001 2.05 1.65—2.55  < 0.001
Black water fever (haemoglobinuria) 237 (4.4) 58 (32.0) 1.49 1.08—2.05 0.014 1.58 1.09—2.27 0.014
Severe jaundice 114 (2.1) 49 (50) 3.21 2.15– 4.79  < 0.001 3.46 2.21- 5.43  < 0.001
Anuria /Oliguria 7 (0.1) 6 (85.7) 18.75 2.25–155.9 0.007
Hyperparasitaemia 100 (1.8) 14 (15.6) 0.57 0.32 –1.01 0.053
Mild anaemia (< 10 −5) 2705 (55.0) 593 (23.6) 1.54 1.24- 1.91  < 0.001 1.28 1.01—1.62 0.04
severe anaemia (> 5) 1431 (29.1) 393 (29.9) 2.13 1.69–2.67  < 0.001 1.77 1.36—2.29  < 0.001
Base excess: More than -8 mmol/L (reference) 2286 (49.9) 290 (12.9)
Severe metabolic acidosis 2296 (50.1) 800 (35.6) 3.73 3.21 – 4.33  < 0.001
Blood Glucose: hypoglycaemia: < 3 mmol/L), 
No Hypoglycaemia (Reference)
557 (10.3) 223 (45.7) 3.02 2.49–3.67  < 0.001 2.77 2.22—3.46  < 0.001
Fig. 3 Calibration plot of uraemia model
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metabolic acidosis or acute kidney injury, which could 
then be selected for further laboratory work-up. Diag-
nosing these complications is important for the clinical 
management, monitoring, and, in the case of AKI, decid-
ing on potential kidney replacement therapy.
Severe metabolic acidosis
In this study, the clinical features associated with severe 
metabolic acidosis in children with severe falciparum 
malaria at admission were young age and prostration at 
admission. Clinical features that contributed to severe 
metabolic acidosis were severe anaemia, hypoglycaemia, 
acute kidney injury and black water fever. Features occur-
ring because of severe metabolic acidosis were respira-
tory distress, deep breathing and coma at admission. All 
signs can be used to identify the group with a high prob-
ability of having severe metabolic acidosis.
Similar findings were identified in a prognostic study 
in The Gambia with discriminative performance (ROC: 
0.83) [17]. This study identified; low Blantyre coma score 
(BCS: 0–2), high parasitaemia, high respiratory rate for 
age and deep breathing as clinical features associated 
with hyperlactataemia in children with severe malaria 
[17]. Hyperparasitaemia was not associated with severe 
metabolic acidosis in this study and, this may be attrib-
uted to the study in The Gambia occurring in a low trans-
mission setting.
Signs of respiratory distress are commonly associated 
with severe metabolic acidosis, as is the finding in this 
study and studies in The Gambia, Malawi and Kenya [19, 
24, 26, 32]. Despite the potential overlap between respira-
tory distress from severe malaria and severe pneumonia, 
the data suggest that respiratory distress is a major inde-
pendent predictor of severe metabolic acidosis [33–35].
This study suggests that deep breathing is a strong 
independent predictor of severe metabolic acidosis as 
it is an important element of respiratory compensa-
tion as a consequence of metabolic acidosis [36]. In 
this study, children with severe malaria presenting with 
deep breathing were 8 times more likely to have severe 
metabolic acidosis upon univariable analysis (OR: 8.74, 
CI 7.11 -10.74). Although inter-observer variability may 
affect the use of this sign as a surrogate marker for severe 
metabolic acidosis, it may be a reliable starting point for 
screening for children who require specialized manage-
ment upon admission [37].
In this study, younger children were more likely to 
have Severe Metabolic Acidosis upon admission with 
severe malaria. Although a study in South East Asia 
found that metabolic acidosis did not vary with age, the 
findings from this study are consistent with clinical tri-
als in Tanzania [2, 38]. This may suggest that the higher 
transmission rates of malaria in Africa increase the odds 
of severe metabolic acidosis in children.
Mtove et al. found that severe anaemia and hypoglycae-
mia were significantly associated with hyperlactataemia 
upon univariable logistic regression, as was the case in 
this study [38]. Severe anaemia is a known complication 
of malaria and contributes to fluid depletion and hypoxia 
in children with severe malaria and, hypoglycaemia is 
a major cause of mortality in children with malaria [9]. 
These are complications of malaria that contribute to 
causing severe metabolic acidosis.
In contrast with this study, Newton et  al. found deep 
breathing, coma, and hypoglycaemia to be highly spe-
cific for hyperlactatemia in three different countries [20]. 
Their study concluded that these were not reliable surro-
gate markers of severe metabolic acidosis [20].
The model generated in this study performed well and, 
upon internal validation, deep breathing, hypoglycaemia, 
and coma were reliable prognostic predictors of severe 
metabolic acidosis. Prospective, external validation stud-
ies are recommended to explore the generalizability of 
this model. To contribute to the improvement of the clin-
ical management of these complications, further studies 
should study the effect of blood transfusions, fluid man-
agement and oxygen support to children identified as 
severe metabolic acidosis.
Uraemia
Older children and children who presented with coma, 
jaundice and hypoglycaemia were more likely to be urae-
mic upon admission with severe malaria in this analy-
sis. Children who presented with decompensated shock, 
blackwater fever, anaemia (mild and severe), anuria and 
severe metabolic acidosis were also more likely to have 
uraemia.
AKI is often underdiagnosed in children, and an 
observed prevalence of uraemia, of 24%, among all severe 
malaria admissions and 49% among all children who died 
in this study  is alarming. A study in the Gambia found 
that 25% of children with cerebral malaria had a glomer-
ulo-tubular pattern of kidney pathology [39]. Although 
that study lacked the power to suggest a significant asso-
ciation between mortality and AKI in severe malaria, it 
is consistent with the strong significance of coma as an 
associated feature to AKI in this study [39].
In this study, only 7 children had oliguria (out of 5426) 
and all of them had uraemia. This may reflect incon-
sistencies in defining oliguria, as this variable was not 
objectively measured through catheterization. However, 
absence of oliguria does not exclude kidney injury one 
study found that 75% of patients with acute kidney failure 
secondary to severe malaria were non-oliguric [40].
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While black water fever was significantly associated 
with uraemia, it was present in only 237 of 5426 chil-
dren (4.4%) [4]. Children with severe falciparum malaria 
in India had an AKI incidence of 19% though none had 
black water fever [41]. In contrast, black water fever was 
the leading cause of AKI among children in a nephrology 
unit in the Democratic Republic of Congo [12]. Addition-
ally, in Uganda AKI was associated with haemoglobinuria 
in children cerebral malaria and severe malaria anaemia 
[23].
The findings of anaemia (mild and severe) and decom-
pensated shock being significantly associated with AKI 
are consistent with studies that identify the role of dehy-
dration in the development of AKI in severe malaria [12, 
39, 41]. Further study is needed to understand appropri-
ate fluid management in children as fluid bolus resusci-
tation was associated with increased mortality in a large 
trial [42].
The analysis from this study suggests that severe meta-
bolic acidosis and uraemia are interrelated. Hypoglycae-
mia, coma and severe anaemia are features common to 
these two outcomes. This could reinforce these as major 
targets for clinical interventions. In addition to support-
ive care, patients would require rehydration with intrave-
nous fluids, but not with fluid bolus therapy as discussed 
in the FEAST study [42]. Dialysis could be started early 
if AKI is confirmed, and further study is needed to guide 
dialysis for treatment of severe metabolic acidosis irre-
spective of concomitant kidney failure.
Increasing age was significantly associated with urae-
mia in this study. Similarly, a higher mean age of kidney 
involvement in children with severe malaria was seen 
in the DRC (6.7  years), India (7.7  years) and south-east 
Asia [2, 12, 41]. This was attributed to a delay of acquired 
immunity and increase of severe malaria in older children 
as malaria prevention efforts intensified for younger chil-
dren over the years. This may be on on-going trend, as 
an observational study in Kenya found that between 1989 
and 2016, there was a marked increase in the mean age 
of children presenting with cerebral malaria and in those 
who died from malaria related causes, when compared to 
those presenting without malaria related conditions [33].
Although the model generated in this study can be 
used in these settings, it may also be useful to invest in 
biomarker diagnoses for AKI in African hospitals. An 
example is the saliva urea nitrogen dipstick test that has 
been shown to be useful in identifying AKI in children 
and adults with severe malaria [43, 44].
Limitations
A major limitation was the inability to follow up the 
clinical progress of severe metabolic acidosis or urae-
mia for the study participants bacause this study was a 
retrospective analysis. There is a risk of inter-observer 
variation in identifying clinical signs which may over or 
under emphasize the presence of some features. Sec-
ondly, there is possible collinearity between uraemia 
and severe metabolic acidosis as there were clinical fac-
tors common to both outcomes. However, the analysis in 
this study was unable to explore the implications of the 
collinearity on presentation at admission or prognosis 
in children with severe malaria. A previously developed 
model for severe metabolic acidosis [38], could not be 
tested due to differences in how severe metabolic acido-
sis was measured. Despite this, the performance of both 
models and the clinical factors identified to be associated 
with severe metabolic acidosis, were similar to those in 
this study. Lastly, studying kidney injury was limited to 
analysing blood urea nitrogen levels. Creatinine and 
urine output were not available for this analysis and AKI 
could not be defined by KIDGO standards.
Conclusions
A secondary analysis was conducted of a large clinical 
trial spanning nine African countries to identify prog-
nostic features of severe metabolic acidosis and uraemia 
in children with severe malaria. Identifying children who 
are likely to have these complications could help triage 
patients requiring further treatment or specialized ther-
apy. Health policies should consider structures for early 
identification and treatment of these complications to 
reduce mortality from malaria.
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